A team of doctors from Deutsches Zentrum Immuntherapie at Uniklinikum Erlangen has succeeded for the first time in treating a young patient with a severe case of therapy-resistant inflammatory bowel disease (ulcerative colitis) with cell therapy using CD19-CAR-T cells. The results of this innovative treatment have been published in the latest issue of the New England Journal of Medicine.
/FAU Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
